The Claim
Omega-3 fatty acid supplementation at 2000 mg/day for 90 days has no statistically significant effect on high-sensitivity C-reactive protein (hsCRP) levels in adults, regardless of PPARG polymorphism status, indicating that the lipid-lowering effect of omega-3s is not mediated through modulation of systemic inflammation in this population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 2000 mg of omega-3 fish oil daily for three months doesn't lower a common marker of body inflammation called hsCRP, no matter what your genes say. So, if omega-3s help your cholesterol, it's probably not because they're calming down inflammation.
See the scientific wording
Omega-3 fatty acid supplementation at 2000 mg/day for 90 days does not significantly reduce high-sensitivity C-reactive protein (hsCRP) in adults with or without PPARG polymorphisms, indicating that the lipid-lowering effect is independent of systemic inflammation modulation in this population.
What the research says
1 studyTaking 2000 mg of omega-3 daily for 90 days lowered bad fats in the blood for some people, but it didn’t reduce a marker of body inflammation called hsCRP — meaning the good effects on fats happen without calming inflammation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.